Effects of loperamide on ileoanal pouch function

Area of Science:

• Gastroenterology
• Pharmacology
• Surgical outcomes

Background:

• Opioid analogues like loperamide are used to manage increased bowel frequency in patients with an ileoanal reservoir.
• The efficacy of loperamide and its impact on pouch motility require further clinical investigation.

Purpose of the Study:

• To determine the clinical efficacy of loperamide in patients with an ileoanal reservoir.
• To assess the effect of loperamide on pouch motility and bowel frequency.

Main Methods:

• Fourteen patients with ileoanal reservoirs underwent 24-hour ambulatory pouch and anal motility recordings, and stool weight measurements.
• Measurements were taken both without medication and with 8 mg of loperamide daily.
• Patients were stratified into 'good function' (≤4 motions/day) and 'poor function' (>6 motions/day) groups for differential analysis.

Main Results:

• Loperamide significantly decreased median bowel frequency (5.5 to 4.0, P=0.03) and 24-hour stool weight (610g to 413g, P=0.03).
• Patients with poor function exhibited higher baseline bowel frequency and stool weight compared to those with good function.
• High-amplitude pouch pressure waves, associated with poor function, were not reduced by loperamide in that group, unlike in the good function group.

Conclusions:

• Loperamide at 8 mg/day reduces bowel frequency primarily by decreasing total stool weight.
• Loperamide impacts pouch motility in patients with good bowel function.
• Increased pouch high-pressure waves are linked to high bowel frequency in ileoanal reservoir patients.